MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte

Melanoma Research

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Lethé, Bernard ^a   Van der Bruggen, Pierre ^a   Brasseur, Francis ^a   Boon, Thierry ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cytotoxic T lymphocytes; HLA A1; Lysis assay; MAGE 1; Quantitative reverse transcription polymerase chain reaction; Recognition threshold; Tumour antigen; Tumour necrosis factor assay

Indexed keywords

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CYTOTOXICITY, IMMUNOLOGIC; HLA-A1 ANTIGEN; HUMANS; MELANOMA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030777911     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-1647.
2. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176:1453-1457.
3. Brasseur F, Rimoldi D, Liénard D, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995; 63:375-380.
4. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994; 40:360-369.
5. Rogner UC, Wilke K, Steck E, Korn B, Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq2K. Genomics 1995; 29:725-731.
6. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995; 55:3478-3482.
7. Haas GG Jr, D'Cruz OJ, De Bault LE. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am J Reprod Immunol Microbiol 1988; 18:47-51.
8. Brower RC, England R, Takeshita T, et al. Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol 1994; 31:1285-1293.
9. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996; 4:565-571.
10. Hérin M, Lemoine C, Weynants P, et al. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 1987; 39:390-396.
11. Van den Eynde B, Hainaut P, Hérin M, et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989; 44:634-640.
12. Gaugler B, Van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179:921-930.
13. Boon T, Van Snick J, Van Pel A, Uyttenhove C, Marchand M. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med 1980; 152:1184-1193.
14. Traversari C, van der Bruggen P, Van den Eynde B, et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992; 35:145-152.
15. Espevik T, Nissen-Meyer J. A highly sensitive cell line. WEHI 164 clone 13, for measuring cytotoxic factor tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95:99-105.
16. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth cell kill. J Immunol Methods 1989; 119:203-210.
17. Davis LG, Dibner MD, Battey JF. Basic Methods in Molecular Biology. New York: Elsevier, 1986.
18. Arnett KL, Parham P. HLA class I nucleotide sequences. Tissue Antigens 1995; 46:217-257.
19. Blasczyk R, Hahn U, Wehling J, Huhn D, Salama A. Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 1995; 46:86-95.
20. De Plaen E, Lurquin C, Lethé B, et al. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. Methods: A Companion to Methods Enzymol 1997; 12 (in press).
21. Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int J Cancer 1992; 52:839-841.
22. De Smet C, Lurquin C, van der Bruggen P, De Plaen E, Brasseur F, Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994; 39:121-129.
23. Le Cras TD, Gherardi E, Bowyer DE. A sensitive RNase protection assay for the quantitation of the mRNAs for the LDL receptor and HMG-CoA reductase in human total RNA. Atherosclerosis 1991; 90:81-90.
24. Babu JS, Kanangat S, Rouse BT. Limitations and modifications of quantitative polymerase chain reaction. J Immunol Methods 1993; 165:207-216.
25. Brichard V, Van Pel A, Wölfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178:489-495
26. Guilloux Y, Lucas S, Brichard VG, et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med 1996; 183:1173-1183.
27. Brichard VG, Herman J, Van Pel A, et al. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 1996; 26:224-230.
28. Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63:883-885.